Generate a tailored SOP for Dr. Tikvah Hayes. Improve your application with a focused, well-structured draft.
Tikvah Hayes is an Assistant Professor in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles. Her research focuses on the basic pre-clinical mechanisms surrounding oncogene dependency, signal transduction, and therapeutic strategies. She aims to describe the underlying mechanisms driving the transition from a normal cell state to a diseased cell state and how the diseased cell state responds to available therapeutic regimens. A significant challenge facing current cancer care is the identification and understanding of variants of unknown significance (VUS) that contribute to the development of resistance to targeted therapies. The lab strives to establish systematic methods to proactively assess the functionality of these unknown variants in cancer. Tikvah's research employs high-throughput genetic screening, novel assay development, and molecular biology techniques to investigate the mechanisms underlying sensitivity and resistance to targeted therapies. Through these efforts, she aims to understand variant biology to improve clinical outcomes in cancer patients.
University of California, Los Angeles • Los Angeles, CA
Working in the Department of Molecular and Medical Pharmacology, focusing on oncogene dependency and therapeutic strategies.
Department of Economics admits primarily for the PhD program.